Effectiveness of MD on MetS Patients
- Conditions
- Obesity
- Registration Number
- NCT06961682
- Lead Sponsor
- Assiut University
- Brief Summary
The metabolic syndrome (MetS), is a complicated condition linked to coronary artery disease.This group includes visceral obesity (abdominal or android type obesity), insulin resistance (IR), hypertension, and dyslipidaemia.The global prevalence of MetS is estimated to be about one-quarter of the world population or over a billion global citizens .A high MetS prevalence of 55% was found in Egyptians, 85.6% among diabetics, and 76.6% among hypertensive patients .People can modify their diet, physical activity, decrease smoking habits to lower their chance of developing MetS. Frequent exercise can lower blood pressure while increasing insulin sensitivity, lipolysis, and energy expenditure. It has the ability to improve blood lipid parameters .Diet is one of the most important tools available to improve MetS. However, the diet for the prevention and treatment of MetS remains unspecified beyond weight control and reduction in total calories. Several evidences show that it should generally be low in saturated fats, trans fats, cholesterol, sodium and simple sugars .The adherence to the Mediterranean Diet(MD) brings up two positive features, firstly the activity levels are increased and secondly the environmental impact becomes self-rewarding. The more the MD is favoured, the more the self-productivity is achieved resulting in a stronger life style adaptation .MD causes reduction of CVD incidence and outcomes decreases BP (systolic and diastolic) , inverses association with mortality,improvements in dyslexia, decreases incidence of T2DM.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 170
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Assessment the effectiveness of MD on obese MetS patients 6 months by measuring weight in kg and height in meters to calculate BMI which equal weight\\height square meters before and after MD at 3 and 6 months
Assessment the effectiveness of MD on hypertensive MetS patients 6 months by regular measuring to blood pressure mmHg before and after the MD
Assessment the effectiveness of MD on diabetic MetS patients 6 months by measuring Hga1c before and after the MD
Assessment the effectiveness of MD on dyslipidemic MetS patients 6 months by measuring lipid profile HDL, LDL, TG
- Secondary Outcome Measures
Name Time Method